Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion

Cornea

Volumn 19, Issue 4, 2000, Pages 492-496

  Turner, Kathleen ^a   Pflugfelder, Stephen C ^a   Ji, Zhonghua ^a   Feuer, William J ^a   Stern, Michael ^b   Reis, Brenda L ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b ALLERGAN INC   (United States)

Author keywords

Conjunctiva; Cyclosporin A; Dry eye disease; Interleukin 6; Keratoconjunctivitis sicca

Indexed keywords

CYCLOSPORIN A; DRUG VEHICLE; FLUORESCEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 6; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVA EPITHELIUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRY EYE; EMULSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPRESSION CYTOLOGY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

ADMINISTRATION, TOPICAL; BIOLOGICAL MARKERS; CONJUNCTIVA; CYCLOSPORINE; DNA PRIMERS; DOUBLE-BLIND METHOD; DRY EYE SYNDROMES; EMULSIONS; EPITHELIUM; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-6; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033911080     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200007000-00018     Document Type: Article

References (18)

1. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathophysiology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584-9.
2. Pflugfelder SC, Wilhelmus KR, Osato AS, Matoba AY, Font RL. The autoimmune nature of aqueous tear deficiency. J Ophthalmol 1986; 93:1513-7.
3. Damato BE, Allan D, Murray SB, Lee WR. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol 1984;68:674-80.
4. Williamson J, Gibson AAM, Wilson T, Forrester JV, Whaley K, Dick WC. Histology of the lacrimal gland in keratoconjunctivitis sicca. Br J Ophthalmol 1973;57:852-8.
5. Jones DT, Monroy D, Ji Z, Atherton SS, Pflugfelder SC. Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci 1994;35:3493-504.
6. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999;19:201-11.
7. Raphael M, Bellefgih S, Piette JCH. Conjunctival biopsy in Sjögren's syndrome: correlations between histological and immunohistochemical features. Histopathology 1988;13:191-202.
8. Gunduz K, Ozdemir O. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome. Acta Ophthalmol 1994;72:435-442.
9. Sail K, Stevenson OD, Mundorf TK, Reis BL, CsA Phase 3 Study Group. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology 2000;107:631-9.
10. Laibovitz RA, Solch S, Andriano K, O'Connell M, Silverman MH. Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca. Cornea 1993;12:315-23.
11. Iacono AT, Smaldone GC, Keenan RJ, et al. Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Am J Respir Crit Care Med 1997;155:1690-8.
12. Haendler B, Hofer-Warbinek R, Hofer E. Complementary DNA for human T-cell cyclophilin. EMBO J 1987;6:947-50.
13. Ryffel B, Woerly G, Greiner B, Haendler B, Mihatsch MJ, Foxwell BM. Distribution of the cyclosporin binding protein cyclophilin in human tissues. Immunology 1992;72:399-404.
14. Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK. Effect of cyclosporine ophthalmic emulsion on the number of inflammatory cells and goblet cells in conjunctival biopsies of patients with dry eye [ARVO abstract]. Invest Ophthalmol Vis Sci 1999;40(4):S771.
15. Tsubota K, Fujihara T, Saito K, Takeuchi T. Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica 1999; 213:16-19.
16. Fleiss JL. The design and analysis of clinical experiments. New York: Wiley, 1986.
17. Wood LC, Stadler K, Liou A, et al. Barrier disruption increases gene expression of cytokines and the 55kD TNF receptor in murine skin. Exp Dermatol 1997;6:98-104.
18. Man MQ M, Feingold KR, Thorfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol 1996; 106:1096-101.